Scholar Rock Holding Corp (SRRK) stock
SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$45.08+0.54 (+1.21%)
Close on Nov 17, 2026Market cap $5.49BP/E –Yield –
Scholar Rock cash
Cash and short-term investments held at the end of each period.
Scholar Rock's cash was $492.09M at Jun 30, 2026. For fiscal 2025 it was $367.56M, down 16.4% from the year before. The highest annual figure on record is $439.69M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $367.56M | -16.4% |
| FY2024 | Dec 31, 2024 | $439.69M | +55.7% |
| FY2023 | Dec 31, 2023 | $282.35M | -11.2% |
| FY2022 | Dec 31, 2022 | $317.86M | +24.4% |
| FY2021 | Dec 31, 2021 | $255.49M | -25.6% |
| FY2020 | Dec 31, 2020 | $343.53M | +114.8% |
| FY2019 | Dec 31, 2019 | $159.95M | -9.0% |
| FY2018 | Dec 31, 2018 | $175.85M | +202.3% |
| FY2017 | Dec 31, 2017 | $58.16M | +468.1% |
| FY2016 | Dec 31, 2016 | $10.24M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $492.09M | +66.8% |
| Q1 FY2026 | Mar 31, 2026 | $479.94M | +31.7% |
| Q4 FY2025 | Dec 31, 2025 | $367.56M | -16.4% |
| Q3 FY2025 | Sep 30, 2025 | $369.63M | +165.8% |
| Q2 FY2025 | Jun 30, 2025 | $295.01M | +54.9% |
| Q1 FY2025 | Mar 31, 2025 | $364.38M | +52.8% |
| Q4 FY2024 | Dec 31, 2024 | $439.69M | +55.7% |
| Q3 FY2024 | Sep 30, 2024 | $139.07M | -36.4% |
| Q2 FY2024 | Jun 30, 2024 | $190.49M | -23.4% |
| Q1 FY2024 | Mar 31, 2024 | $238.43M | -13.4% |
| Q4 FY2023 | Dec 31, 2023 | $282.35M | -11.2% |
| Q3 FY2023 | Sep 30, 2023 | $218.64M | -36.4% |
| Q2 FY2023 | Jun 30, 2023 | $248.73M | -32.9% |
| Q1 FY2023 | Mar 31, 2023 | $275.28M | +31.0% |
| Q4 FY2022 | Dec 31, 2022 | $317.86M | +24.4% |
| Q3 FY2022 | Sep 30, 2022 | $343.66M | +39.5% |
| Q2 FY2022 | Jun 30, 2022 | $370.69M | +31.3% |
| Q1 FY2022 | Mar 31, 2022 | $210.21M | -33.2% |
| Q4 FY2021 | Dec 31, 2021 | $255.49M | -25.6% |
| Q3 FY2021 | Sep 30, 2021 | $246.44M | +112.0% |
| Q2 FY2021 | Jun 30, 2021 | $282.22M | +99.9% |
| Q1 FY2021 | Mar 31, 2021 | $314.69M | +95.9% |
| Q4 FY2020 | Dec 31, 2020 | $343.53M | +114.8% |
| Q3 FY2020 | Sep 30, 2020 | $116.26M | -34.0% |
| Q2 FY2020 | Jun 30, 2020 | $141.18M | -23.7% |
| Q1 FY2020 | Mar 31, 2020 | $160.65M | +0.6% |
| Q4 FY2019 | Dec 31, 2019 | $159.95M | -9.0% |
| Q3 FY2019 | Sep 30, 2019 | $176.08M | +69.0% |
| Q2 FY2019 | Jun 30, 2019 | $185.13M | +60.6% |
| Q1 FY2019 | Mar 31, 2019 | $159.67M | +593.4% |
| Q4 FY2018 | Dec 31, 2018 | $175.85M | +202.3% |
| Q3 FY2018 | Sep 30, 2018 | $104.19M | +930.5% |
| Q2 FY2018 | Jun 30, 2018 | $115.27M | +1535.4% |
| Q1 FY2018 | Mar 31, 2018 | $23.03M | +124.9% |
| Q4 FY2017 | Dec 31, 2017 | $58.16M | – |
| Q3 FY2017 | Sep 30, 2017 | $10.11M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.05M | – |
| Q4 FY2016 | Dec 31, 2016 | $10.24M | – |
See a number that looks wrong?